UPDATE: Jefferies Upgrades Supernus Pharmaceuticals (SUPN) to Buy Positive Survey Drives Peak Sales to $600M
Tweet Send to a Friend
(Updated - April 13, 2021 8:09 AM EDT)
Jefferies analyst David Steinberg upgraded Supernus Pharmaceuticals (NASDAQ: SUPN) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst David Steinberg upgraded Supernus Pharmaceuticals (NASDAQ: SUPN) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
